104 related articles for article (PubMed ID: 8983937)
1. Comparative pharmacokinetics and bioavailability of two oral formulations of thiocolchicoside, a GABA-mimetic muscle relaxant drug, in normal volunteers.
Perucca E; Poitou P; Pifferi G
Eur J Drug Metab Pharmacokinet; 1995; 20(4):301-5. PubMed ID: 8983937
[TBL] [Abstract][Full Text] [Related]
2. Single-dose bioavailability of oral and intramuscular thiocolchicoside in healthy volunteers.
Sandouk P; Bouvier d'Yvoire M; Chretien P; Tillement JP; Scherrmann JM
Biopharm Drug Dispos; 1994 Jan; 15(1):87-92. PubMed ID: 8161719
[TBL] [Abstract][Full Text] [Related]
3. New metabolic and pharmacokinetic characteristics of thiocolchicoside and its active metabolite in healthy humans.
Trellu M; Filali-Ansary A; Françon D; Adam R; Lluel P; Dubruc C; Thénot JP
Fundam Clin Pharmacol; 2004 Aug; 18(4):493-501. PubMed ID: 15312157
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.
Markowitz JS; Straughn AB; Patrick KS; DeVane CL; Pestreich L; Lee J; Wang Y; Muniz R
Clin Pharmacokinet; 2003; 42(4):393-401. PubMed ID: 12648029
[TBL] [Abstract][Full Text] [Related]
5. Comparative bioavailability and tolerability study of two intramuscular formulations of thiocolchicoside in healthy volunteers.
Ferrari MP; Gatti G; Fattore C; Fedele G; Novellini R
Eur J Drug Metab Pharmacokinet; 2001; 26(4):257-62. PubMed ID: 11808868
[TBL] [Abstract][Full Text] [Related]
6. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
7. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study.
Li KY; Liang JP; Hu BQ; Qiu Y; Luo CH; Jiang Y; Lin XP; Yang N
Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325
[TBL] [Abstract][Full Text] [Related]
8. A new esomeprazole packet (sachet) formulation for suspension: in vitro characteristics and comparative pharmacokinetics versus intact capsules/tablets in healthy volunteers.
Bladh N; Blychert E; Johansson K; Backlund A; Lundin C; Niazi M; Pettersson G; Fjellman M
Clin Ther; 2007 Apr; 29(4):640-9. PubMed ID: 17617287
[TBL] [Abstract][Full Text] [Related]
9. Single- and repeated-dose pharmacokinetics of intramuscular thiocolchicoside in healthy volunteers.
Weinling E; Sandouk P; Debray M; Scherrmann JM
Int J Clin Pharmacol Ther; 1999 Oct; 37(10):503-9. PubMed ID: 10543318
[TBL] [Abstract][Full Text] [Related]
10. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
[TBL] [Abstract][Full Text] [Related]
11. Oral absorption characteristics and pharmacokinetics of colchicine in healthy volunteers after single and multiple doses.
Ferron GM; Rochdi M; Jusko WJ; Scherrmann JM
J Clin Pharmacol; 1996 Oct; 36(10):874-83. PubMed ID: 8930773
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of the controlled-release nisoldipine coat-core tablet formulation.
Heinig R; Ahr G; Hayauchi Y; Kuhlmann J
Int J Clin Pharmacol Ther; 1997 Aug; 35(8):341-51. PubMed ID: 9266290
[TBL] [Abstract][Full Text] [Related]
13. Buccal delivery of thiocolchicoside: in vitro and in vivo permeation studies.
Artusi M; Santi P; Colombo P; Junginger HE
Int J Pharm; 2003 Jan; 250(1):203-13. PubMed ID: 12480286
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS
Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
16. Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects.
Henney HR; Shah J
Clin Ther; 2007 Apr; 29(4):661-9. PubMed ID: 17617289
[TBL] [Abstract][Full Text] [Related]
17. Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers.
Shah J; Wesnes KA; Kovelesky RA; Henney HR
Clin Ther; 2006 Sep; 28(9):1308-17. PubMed ID: 17062304
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of valproic acid after administration of three oral formulations in healthy adults.
Bano G; Gupta S; Gupta KL; Raina RK
J Assoc Physicians India; 1990 Sep; 38(9):629-30. PubMed ID: 2266076
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic properties and bioequivalence of 2 formulations of valsartan 160-mg tablets: A randomized, single-dose, 2-period crossover study in healthy Korean male volunteers.
Kim JE; Ki MH; Yoon IS; Cho HJ; Kim RS; Tae Kim G; Kim DD
Clin Ther; 2014 Feb; 36(2):273-9. PubMed ID: 24529292
[TBL] [Abstract][Full Text] [Related]
20. Setipiprant, a selective oral antagonist of human CRTH2: relative bioavailability of a capsule and a tablet formulation in healthy female and male subjects.
Baldoni D; Mackie A; Gutierrez M; Theodor R; Dingemanse J
Clin Ther; 2013 Nov; 35(11):1842-8. PubMed ID: 24095247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
